LANNETT Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LANNETT, and what generic and branded alternatives to LANNETT drugs are available?
LANNETT has one hundred and thirty-two approved drugs.
There is one tentative approval on LANNETT drugs.
Summary for LANNETT
| US Patents: | 0 |
| Tradenames: | 97 |
| Ingredients: | 94 |
| NDAs: | 132 |
| Patent Litigation for LANNETT: | See patent lawsuits for LANNETT |
| PTAB Cases with LANNETT as petitioner: | See PTAB cases with LANNETT as petitioner |
Drugs and US Patents for LANNETT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | NITROGLYCERIN | nitroglycerin | FILM, EXTENDED RELEASE;TRANSDERMAL | 075115-002 | Aug 10, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Lannett Co Inc | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | TABLET;ORAL | 215565-002 | Jul 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett Co Inc | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 089743-001 | Aug 25, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LANNETT drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
